Literature DB >> 7366893

Management of sickle cell disease in pregnant patients.

S Charache, J Scott, J Niebyl, D Bonds.   

Abstract

Data from a total of 74 pregnancies in 42 patients with sickling disorders seen at Johns Hopkins Hospital are compared with similar data from other centers. Although risks are still higher than those for women without sickle cell disease, they have diminished significantly from those reported earlier. Prophylactic transfusion therapy may decrease these risks further, but benefits of transfusion are unproved at present. Patients with sickling disorders should receive meticulous individualized treatment until further data are made available.

Entities:  

Mesh:

Year:  1980        PMID: 7366893

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  Sickle cell states and the anaesthetist.

Authors:  D W Esseltine; M R Baxter; J C Bevan
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

2.  Sickle haemoglobin and pregnancy.

Authors:  G R Serjeant
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-03

3.  Clinical complications in pregnant women with sickle cell disease: prospective study of factors predicting maternal death or near miss.

Authors:  Patrícia Santos Resende Cardoso; Regina Amélia Lopes Pessoa de Aguiar; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2014-05-29

4.  Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory.

Authors:  Jean-Antoine Ribeil; Myriam Labopin; Aurélie Stanislas; Benjamin Deloison; Delphine Lemercier; Anoosha Habibi; Souha Albinni; Caroline Charlier; Olivier Lortholary; François Lefrere; Mariane De Montalembert; Stéphane Blanche; Frédéric Galactéros; Jean-Marc Tréluyer; Eliane Gluckman; Yves Ville; Laure Joseph; Marianne Delville; Alexandra Benachi; Marina Cavazzana
Journal:  Am J Hematol       Date:  2018-04-17       Impact factor: 10.047

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.